Key Developments: Reed Elsevier NV (ENL)

ENL on New York Consolidated

46.01USD
31 Oct 2014
Price Change (% chg)

$0.33 (+0.72%)
Prev Close
$45.68
Open
$45.86
Day's High
$46.09
Day's Low
$45.79
Volume
8,510
Avg. Vol
49,491
52-wk High
$46.69
52-wk Low
$39.68

Search Stocks

Latest Key Developments (Source: Significant Developments)

Reed Elsevier NV increases number of outstanding shares
Sunday, 5 Oct 2014 08:00pm EDT 

Reed Elsevier NV:Announces that 372,361 new ordinary shares issued by the company, immediately assimilated with the existing ordinary shares, will be listed on the market Euronext Amsterdam as of Oct. 7.Says the old number of outstanding shares is 736,255,437.Says the number of shares to be listed is 372,361.Says the new number of outstanding shares is 736,627,798.Says the reason is exercise of option.  Full Article

Reed Elsevier NV to pay FY 2014 interim dividend
Monday, 28 Jul 2014 08:00pm EDT 

Reed Elsevier NV:To pay gross FY 2014 interim dividend of 0.151 euro per share (0.12835 euro per share net).Record date: Aug. 8.Ex-date: Aug. 6.Payment date: Aug. 28.  Full Article

Reed Technology and Information Services acquires PatentCore
Tuesday, 8 Jul 2014 09:05am EDT 

Reed Elsevier NV:Reed Technology and Information Services Inc., LexisNexis company, acquires PatentCore, Minneapolis-based developer of LexisNexis PatentAdvisorSM solution suite.Acquisition to enhance LexisNexis intellectual property (IP) offerings and give customers access to broader range of IP services.PatentAdvisor joins LexisNexis TotalPatent, LexisNexis PatentOptimizer, LexisNexis IP DataDirect and IP Services (formerly ReedFax) as part of portfolio of IP solutions.  Full Article

Elsevier to Collaborate with Knewton to build adaptive learning products for nursing, health professions, and medical students globally
Thursday, 12 Jun 2014 07:32am EDT 

Elsevier:Elsevier collaborates with Knewton starting with courses for nursing and health professions students, Elsevier will use Knewton's infrastructure to power personalized digital solutions that continuously adjust to each individual's unique learning needs.Says Elsevier is part of Reed Elsevier Group PLC which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV.  Full Article

National Funding Agency for Science and Technology selects Reed Elsevier NV's Analytical Services
Tuesday, 10 Jun 2014 10:33am EDT 

Reed Elsevier NV:Says it has been selected by national funding agency for science and technology in Portugal, Fundacao para a Ciencia e a Tecnologia (FCT), to provide bibliometric analyses that will support its 2013/14 national review assessment of R&D units.  Full Article

Reed Elsevier NV and Reed Elsevier PLC subsidiary sells emedia
Tuesday, 3 Jun 2014 08:00pm EDT 

Reed Elsevier NV:Subsidiary Reed Elsevier Group PLC, owned 50/50 together with Reed Elsevier PLC, says its Reed Business Information (RBI) sells emedia Communications LLC, U.S.-based provider of research to IT buyers and leads to IT vendors, to Ziff Davis, digital media division of j2 Global, Inc.Agreement signed as well to sell U.K.-based division of emedia to Ziff Davis, following period of employee consultation.Terms of agreement not disclosed.Signal Hill Capital Group acted as exclusive financial advisor to RBI.  Full Article

Reed Elsevier NV's LexisNexis acquires Wunelli
Monday, 19 May 2014 08:00pm EDT 

Reed Elsevier NV:Says its subsidiary LexisNexis Risk Solutions has acquired Wunelli, a data services company based in the United Kingdom.  Full Article

Reed Elsevier to market Stanson Health CDS system
Wednesday, 23 Apr 2014 08:31am EDT 

Reed Elsevier NV:Announces agreement to market Stanson Health's clinical decision support (CDS) and analytics solution.Stanson's CDS solutions are designed to safely reduce cost and potential for harm from unnecessary care by leveraging user-friendly, real-time alerts and analytics to help guide physicians' decisions.Stanson's CDS solutions to complement Elsevier Clinical Solutions suite including portfolio of solutions for workflow and decision support, clinical reference and drug reference, patient engagement and performance management.  Full Article

Reed Elsevier confirms FY 2014 outlook
Tuesday, 22 Apr 2014 08:00pm EDT 

Reed Elsevier NV:FY 2014 outlook unchanged with revenue, profit and earnings growth expected.FY 2013 revenue 7,121 mln euros.FY 2014 revenue 7,276 mln euros - Thomson Reuters I/B/E/S Estimates.  Full Article

Reed Elsevier NV LexisNexis acquires Tracesmart
Monday, 31 Mar 2014 08:00pm EDT 

Reed Elsevier NV:Subsidiary LexisNexis Risk Solutions acquires U.K.-based Tracesmart.Tracesmart provides consumer data and identity, risk and trace solutions serving UK clients by delivering web-based software for tracing, identity verification/fraud prevention, anti-money laundering, debt collection and data cleansing.Tracesmart's client base includes financial services, life and pension, collections, insurance, retail, gaming, non-profit, public sector and consumer sectors.  Full Article

Reed Elsevier sticks to positive outlook

LONDON, Oct 23 - Anglo Dutch Reed Elsevier said a 4 percent rise in underlying revenue in the first nine months kept it on track to meet its goal of growing revenue and profit this year.

Search Stocks